Proteomic profiling of tear fluid as a promising non-invasive screening test for colon cancer. Kaufmann Y, Byrum SD, Acott AA, Siegel ER, et al. Am J Surg 2022 Mar 25. pii: S0002-9610(22)00207.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kaufmann Y, Byrum SD, Acott AA, Siegel ER, et al. Proteomic profiling of tear fluid as a promising non-invasive screening test for colon cancer. Am J Surg 2022 Mar 25. pii: S0002-9610(22)00207.
PMID: 35354531